الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
61 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
62 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
63 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
64 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021
65 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Duaa Abdel-Samia Mohamed Ali 2021
66 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
67 Micro-RNA 155 in non-Hodgkin lymphoma ميرنا وجيه وديع ناروز 2021
68 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
69 Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues Prof. Douaa Mohamed Sayed Hussein 2021
70 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Mohamed Galal Mostafa ELnaggar 2021